DoubleChecks

What was claimed

MASSIVE BOMBSHELL: THE CANCER INDUSTRY IS HIDING THE CURE! JOHNS HOPKINS HELD THE PATENT ALL ALONG for Mebendazole for treatment and prevention of tumors

Our verdict

Inaccurate

A patent is not evidence of a proven cure. The sources describe a patented formulation and potential anticancer use, not a confirmed cure for cancer. The research is publicly available in peer-reviewed journals, patent databases, and clinical trial registries. Johns Hopkins researchers published their findings showing mebendazole prevented tumor proliferation in mice and the drug is part of a phase I clinical trial. This contradicts any claim of suppression.

Combined assessment31 sourcesChecked Aug 30, 2026

Why this verdict

  • MASSIVE BOMBSHELL: THE CANCER INDUSTRY IS HIDING THE CURE!

    Incorrect
    All assessments reached this conclusion

  • The cancer industry is hiding the cure.

    Can’t verify
    One assessment reached this conclusion

  • Mebendazole was patented for treatment and prevention of tumors.

    Verified
    All assessments reached this conclusion

  • JOHNS HOPKINS HELD THE PATENT ALL ALONG for Mebendazole for treatment and prevention of tumors

    Verified
    Two assessments reached this conclusion; one differed·ChatGPT: Misleading

Evidence reviewed

31 sources

Perplexity and Claude sources are combined here. No source links were stored for ChatGPT.

trial.medpath.compatents.google.compatents.google.compatents.google.comeconomictimes.comonedaymd.comsec.govpatents.google.comlinkedin.comx.com

Individual assessments

Assessment summary

  • The response is partly accurate because Johns Hopkins did obtain a patent titled “Mebendazole polymorph for treatment and prevention of tumors,” and the patent explicitly covers treatment and prevention claims for tumors.
  • But the wording “massive bombshell” and “the cancer industry is hiding the cure” is not supported by the sources, and the patent does not prove mebendazole is a cure for cancer or that it is being hidden.

Claims reviewed

This proves a hidden cancer cure exists.

Incorrect
A patent is not evidence of a proven cure. The sources describe a patented formulation and potential anticancer use, not a confirmed cure for cancer.

This claim may mislead readers without added context.

The cancer industry is hiding the cure.

Can’t verify
The sources provided do not support this allegation. It is a broad conspiracy claim and cannot be established from the patent alone.

Johns Hopkins held the patent for mebendazole for treatment and prevention of tumors.

Verified
The patent record lists The Johns Hopkins University as assignee for US11110079B2, titled “Mebendazole polymorph for treatment and prevention of tumors.”

Assessment summary

  • The claim contains multiple serious distortions.
  • While Johns Hopkins did research mebendazole and holds patents, the framing as a "hidden cure" is false.
  • Clinical trials show only preliminary, mixed results—not a proven cure.
  • The conspiracy narrative contradicts the public, transparent nature of the research.

Claims reviewed

The cancer industry is hiding the cure

Incorrect
The research is publicly available in peer-reviewed journals, patent databases, and clinical trial registries. Johns Hopkins researchers published their findings showing mebendazole prevented tumor proliferation in mice and the drug is part of a phase I clinical trial. This contradicts any claim of suppression.

This claim may mislead readers without added context.

Mebendazole is a cure for cancer

Incorrect
No clinical trials of MBZ as a cancer treatment have been completed to date. Human trials investigating mebendazole for cancer treatment have primarily focused on its safety and tolerability in combination with standard therapies, with limited efficacy data available to date. Early Phase I results show promise in some cases but no proven cure.

This claim may mislead readers without added context.

Mebendazole shows promise for tumor treatment and prevention

Verified
Preclinical studies demonstrated that mebendazole prevented tumor proliferation and improved survival times in mice by an average of 63 percent. Phase I trial results showed a 21-month median overall survival compared to glioblastoma's typical 12-15 months, though larger trials are needed.

Assessment summary

  • The statement mixes a conspiracy claim with a narrower, verifiable patent fact.
  • Johns Hopkins University does own/has applied for patents covering specific mebendazole formulations and polymorphs for cancer uses.
  • The broader claim that the "cancer industry is hiding the cure" is unsubstantiated and misleading.

Claims reviewed

MASSIVE BOMBSHELL: THE CANCER INDUSTRY IS HIDING THE CURE!

Incorrect
There is no credible evidence that the cancer research or medical community is collectively hiding a universal cure for cancer; this is a conspiracy-style claim without verifiable support.

This claim may mislead readers without added context.

JOHNS HOPKINS HELD THE PATENT ALL ALONG for Mebendazole for treatment and prevention of tumors

Misleading
Johns Hopkins University has filed and been granted patents and patent applications on specific mebendazole polymorphs, prodrugs and formulations for cancer indications, but mebendazole as an antiparasitic generic is not a single-secret 'cure' patent covering all uses.

This claim may mislead readers without added context.

Check your own claim

Paste any statement, headline, or AI answer. Independent assessments check it and compare sources.

Share this result